GINA 2025: Key Updates for the Diagnosis and Management of Asthma
At SCHILLER, we understand that your time is valuable and that keeping up with clinical guidelines can be a challenging task. That’s why we’ve prepared this summary of the most important updates in the 2025 edition of the GINA (Global Strategy for Asthma Management and Prevention) Strategy Report—so you can quickly identify the new recommendations […]
The Role of Diffusion Capacity in Lung Disease Detection and Management
The carbon monoxide diffusion lung capacity (DLCO) provides crucial information about the lungs’ ability to transfer oxygen from inhaled air into the bloodstream. For this reason, this test is essential for the diagnosis and monitoring of various pulmonary diseases. In this blog, we analyze its advantages and provide examples of its benefits in clinical practice. […]
Why Is Body Plethysmography with a Booth the Gold Standard?
While spirometry is the most commonly used method for evaluating pulmonary function in clinical practice, there are times when it’s necessary to measure the volume of air the lungs cannot displace (static lung volumes). This is why body plethysmography with a booth remains an essential technique in pulmonary function testing. The first test was conducted […]
Whole Body Plethysmography: A Complete Guide to Lung Volume Analysis
The body plethysmography test is the only precise way to measure lung volumes. With advancements in technology, including ultrasonic flow measurement, modern body plethysmography machines can detect even the smallest changes in pulmonary function. In this article, you’ll find scientific evidence explaining why cabin-based body plethysmography offers unique advantages that establish it as the gold […]
How to Choose a Body Plethysmograph
Body plethysmography is a non-invasive and indispensable method for obtaining detailed information about lung volumes and airway function—data that other pulmonary function tests cannot provide. With the increasing prevalence of respiratory diseases such as asthma, COPD, and the lasting effects of COVID-19, the need for reliable and precise diagnostic tools has never been greater. A […]
Interstitial Lung Disease: The Consequences of Misdiagnoses
Interstitial lung diseases (ILDs) encompass many unrelated conditions with both known and unknown etiologies, which often present diagnostic and therapeutic difficulties for treating physicians. Many believe that early specific diagnosis and immediate management are of no value, as the prognosis and treatment response are universally poor. Due to this belief, many patients experience diagnostic delays […]
EVALI: The critical role of vaping in lung injury cases
Vaping as the Cause of EVALI (E-cigarette or Vaping Product Use–Associated Lung Injury), a pulmonary disease that can be severe and potentially life-threatening. The term was coined at the same time the disease was first recognized in August 2019. It is important to clarify that EVALI is not a clinical diagnosis but a case definition […]
Advanced Oscillometry Insights: Managing Asthma and COPD
Oscillometry is a non-invasive method for measuring the mechanical properties of the respiratory system, which can enhance our understanding and management of lung diseases such as asthma and COPD. This technique offers special advantages in situations where spirometry and other lung function tests are not suitable for patients, such as infants, people with neuromuscular diseases, […]
Press Release: SCHILLER Americas Earns Technology Breakthrough Designation with Premier, Inc.
Doral, Florida – 5/28/2024 – SCHILLER Americas has been awarded a national group purchasing agreement and Technology Breakthrough Designation for Pulmonary Function and Metabolic Analyzers with Premier, Inc. Effective 5/1/2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for tremoflo®. Premier offers Breakthrough […]
2023 American College of Rheumatology Guideline for the Screening and Monitoring of Interstitial Lung Disease in Patients with Systemic AutoimmuneRheumatic Disease
With the aim of providing you with information that may be useful in your medical practice, the Guide have summarized the main recommendations of the 2023 American College of Rheumatology Guideline for the Detection and Monitoring of Interstitial Lung Disease (ILD) in individuals with systemic autoimmune disease. Rheumatic disease. This clinical guideline includes recommendations for […]